Keefe Bruyette initiated coverage on Core Scientific with a new price target
$CORZ
Finance: Consumer Services
Finance
Keefe Bruyette initiated coverage of Core Scientific with a rating of Outperform and set a new price target of $22.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/27/2025 | $22.00 | Outperform | Keefe Bruyette |
| 1/21/2025 | $24.00 | Buy | Craig Hallum |
| 11/15/2024 | $25.50 | Buy | ROTH MKM |
| 10/28/2024 | $19.00 | Buy | Jefferies |
| 9/25/2024 | $16.00 | Outperform | Macquarie |
| 9/23/2024 | $16.00 | Buy | Canaccord Genuity |
| 9/4/2024 | $16.00 | Buy | Needham |
| 7/17/2024 | $20.00 | Overweight | Cantor Fitzgerald |
Company Welcomes Veteran Finance Executive, Jim Nygaard, as New CFO Effective March 17 Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-performance computing (HPC), today announced that Jim Nygaard will succeed Denise Sterling as Executive Vice President and Chief Financial Officer (CFO), effective March 17, 2025. This appointment follows the Company's previously announced CFO transition plan. Mr. Nygaard brings nearly 30 years of investment banking expertise, including extensive M&A, corporate finance, and capital-raising experience. Since 2008, he has served as Managing Director and Head of M&A at XMS Capital Partner
Expands Total Contracted HPC Infrastructure by CoreWeave to Approximately 590 Megawatts of Critical IT Load at Six Core Scientific Sites New Agreement Boosts Total Projected Revenue to $10.2 Billion over 12-year Contract Terms Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-performance computing (HPC) at scale, today announced an expansion of its relationship with CoreWeave, an AI Hyperscaler. The new agreement brings an additional $1.2 billion in contracted revenue across Core Scientific's Denton TX location, solidifying Core Scientific's position as a premier provider of application-specific data centers for HPC wor
Fourth Quarter 2024 Highlights Incurred net loss of $265.5 million due primarily to a $224.7 million non-cash mark-to-market adjustment to warrants and other contingent value right liabilities required by the significant year-over-year increase in our share price Reported operating loss of $39.8 million, a decrease of $43.7 million over fourth quarter 2023 Generated adjusted EBITDA of $13.3 million, a decrease of $43.4 million over fourth quarter 2023 Secured $625 million through a convertible note offering with favorable 0% interest terms Strengthened the balance sheet, ending the quarter with cash and cash equivalents of $836.2 million as of December 31, 2024 Earned 974
144 - Core Scientific, Inc./tx (0001839341) (Subject)
424B3 - Core Scientific, Inc./tx (0001839341) (Filer)
424B3 - Core Scientific, Inc./tx (0001839341) (Filer)
SC 13G - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
Industry Veteran Scott Brueggeman Joins Core Scientific as Chief Marketing Officer to Drive Market Expansion and Visibility Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and digital asset mining, today announced the appointment of Scott Brueggeman as Chief Marketing Officer. With over 20 years of experience in digital infrastructure and technology businesses, Brueggeman will play a pivotal role in strengthening the company's brand presence, driving growth, and expanding market opportunities. Brueggeman brings a proven track record of success in high-growth environments. Most recently, he served
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
4 - Core Scientific, Inc./tx (0001839341) (Issuer)
Fourth Quarter 2024 Highlights Incurred net loss of $265.5 million due primarily to a $224.7 million non-cash mark-to-market adjustment to warrants and other contingent value right liabilities required by the significant year-over-year increase in our share price Reported operating loss of $39.8 million, a decrease of $43.7 million over fourth quarter 2023 Generated adjusted EBITDA of $13.3 million, a decrease of $43.4 million over fourth quarter 2023 Secured $625 million through a convertible note offering with favorable 0% interest terms Strengthened the balance sheet, ending the quarter with cash and cash equivalents of $836.2 million as of December 31, 2024 Earned 974
Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or "the Company"), a leader in digital infrastructure for high-performance computing and bitcoin mining, today announced it will issue financial results for the Company's fiscal year 2024 fourth quarter after financial markets close on Wednesday, February 26, 2025. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the fourth quarter 2024 will be Adam Sullivan, Chief Executive Officer, Denise Sterling, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary
Fiscal Third Quarter 2024 Highlights Incurred net loss of $455.3 million due primarily to a net $408.5 million non-cash mark-to-market adjustment to our warrants and other contingent value right liabilities required as a result of significant quarter-over-quarter increase in the value of our equity Generated operating loss of $41.2 million, an increase of $29.2 million over third quarter 2023 Realized adjusted EBITDA of $10.1 million Customer initiated option exercises resulted in an additional 112 MW during the third quarter and the remaining 120 MW in the fourth quarter for a total of approximately 500 megawatts of critical IT load to host high-performance computing ("HPC"), repre
Keefe Bruyette initiated coverage of Core Scientific with a rating of Outperform and set a new price target of $22.00
Craig Hallum initiated coverage of Core Scientific with a rating of Buy and set a new price target of $24.00
ROTH MKM initiated coverage of Core Scientific with a rating of Buy and set a new price target of $25.50